Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    11-E-0072
Show Display Options
Rank Status Study
1 Recruiting Environmental Risk Factors for the Anti-synthetase Syndrome
Condition: Myositis
Intervention:
2 Completed Effect of LY2062430 on the Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY2062430;   Drug: Placebo
3 Completed Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Condition: Asthma
Interventions: Drug: Mepolizumab IV;   Drug: Mepolizumab SC;   Drug: IV placebo and SC placebo
4 Recruiting Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
Condition: Lupus
Interventions: Drug: BMS-931699;   Drug: Placebo matching BMS-931699

Indicates status has not been verified in more than two years